Esperion Therapeutics, Inc. (ESPR)
2.44
-0.03
(-1.21%)
USD |
NASDAQ |
Mar 13, 16:00
2.55
+0.11
(+4.51%)
After-Hours: 06:01
Esperion Therapeutics Market Cap : 583.31M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.267B |
| Harrow, Inc. | 1.270B |
| Catalyst Pharmaceuticals, Inc. | 2.837B |
| Rigel Pharmaceuticals, Inc. | 479.38M |
| AnaptysBio, Inc. | 1.863B |
Market Cap Related Metrics
| PS Ratio | 1.33 |
| Price | 2.44 |
| Earnings Yield | -8.59% |
| Operating PE Ratio | 8.896 |